PTC Therapeutics (PTCT) Reports Q4 Earnings: What Key Metrics Have to Say Although the revenue and EPS for PTC Therapeutics (PTCT) give a sense of how its business performed in the quarter…
PTC Therapeutics (PTCT) Reports Q4 Loss, Lags Revenue Estimates PTC Therapeutics (PTCT) delivered earnings and revenue surprises of 75% and 3.96%, respectively, for the quarter ended December 2024. Do…
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher? PTC Therapeutics (PTCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming…
PTC Therapeutics (PTCT) Moves 9.0% Higher: Will This Strength Last? PTC Therapeutics (PTCT) saw its shares surge in the last session with trading volume being higher than average. The latest…
Novartis Hold ANA FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat Novartis mit einem Kursziel von 100 Franken auf "Hold" belassen. Die…
Deutsche Bank Research belässt Novartis auf Hold ANA FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat Novartis mit einem Kursziel von 100 Franken auf "Hold" belassen. Die…
PTC Therapeutics (PTCT) Surges 16.5%: Is This an Indication of Further Gains? PTC Therapeutics (PTCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings…
PTCT Stock Rises on Positive Updates on Friedreich Ataxia Program PTC Therapeutics announces positive results from long-term treatment studies on vatiquinone for the treatment of Friedreich ataxia.…
Earnings call: PTC Therapeutics updates on Q2 2024 financials & trials By Investing.com Earnings call: PTC Therapeutics updates on Q2 2024 financials & trials…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT NEW YORK, Aug. 03, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PTC…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Friedreichs Ataxia Market to Grow at a Substantial Growth Rate by 2034, Examines DelveInsight | Key Companies - Retrotope, PTC Therapeutics, Minoryx Therapeutics, Biogen, Lexeo Therapeutics, Larimar Therapeutics The dynamics of Friedreichs ataxia market are anticipated to change as companies across the globe are thoroughly working toward the…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT NEW YORK, July 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
PTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug PTC Therapeutics (PTCT) falls as the ECs advisory committee adopts a negative opinion regarding the renewal of the conditional marketing…
Biotech Stock Roundup: BIIBs Acquisition, PTCT, LRMR Gain on Updates & More News Biogen (BIIB) and PTC Therapeutics, Inc. (PTCT) are in the spotlight following acquisition news and regulatory updates, respectively.…
PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug PTC Therapeutics (PTCT) gains 21% on May 20 after the EC decided against adopting the negative CHMP opinion of January…
Earnings call: PTC Therapeutics reports strong first quarter financials By Investing.com Earnings call: PTC Therapeutics reports strong first quarter financials…
PTC Therapeutics (PTCT) Up on Positive Regulatory Updates PTC Therapeutics (PTCT) submits BLA for gene therapy Upstaza to the FDA and announces plans to resubmit its application for…
Earnings call: PTC Therapeutics reports strong growth and pipeline progress By Investing.com Earnings call: PTC Therapeutics reports strong growth and pipeline progress…